Two antigen products or rapid test kits currently being sold in the market to monitor Covid-19 cases and which were given Product Certifications by the Food and Drug Administration are both a threat to public health and could imperil people’s lives.
The two kits failed the sensitivity tests conducted in September 2020 by the Research Institute for Tropical Medicine (RITM).
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.